Loading…
Cardiol Therapeutics Inc. is projected to rise to $1.53 by 2027, a +20% move from its current price of $1.28. CRDL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.25 | $1.28 | $1.32 | +0.01% |
| May 30 | $1.23 | $1.28 | $1.33 | +0.03% |
| May 31 | $1.22 | $1.28 | $1.34 | +0.04% |
| Jun 1 | $1.21 | $1.28 | $1.35 | +0.05% |
| Jun 2 | $1.21 | $1.28 | $1.36 | +0.07% |
| Jun 3 | $1.20 | $1.28 | $1.37 | +0.08% |
| Jun 4 | $1.19 | $1.28 | $1.38 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.19 | $1.28 | $1.38 | +0.10% |
| Week 2 | $1.16 | $1.28 | $1.42 | +0.19% |
| Week 3 | $1.13 | $1.28 | $1.45 | +0.29% |
| Week 4 | $1.11 | $1.28 | $1.48 | +0.38% |
| Week 5 | $1.10 | $1.29 | $1.51 | +0.48% |
| Week 6 | $1.08 | $1.29 | $1.53 | +0.57% |
| Week 7 | $1.07 | $1.29 | $1.56 | +0.67% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx is in Phase III multinational, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.
The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure.
Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
CRDL is currently priced at $1.32 per share, with a market cap of $152.16M, and is ranked 4016.
Forecasts imply a gradual upside for CRDL, with the 2026 average price at $1.32 (min $0.926, max $1.73), rising to a 2050 average of $11.11 (max $20.84).
The forecast also shows rising ROI over time, from 0% in 2026 to 60.6% in 2030, 99.9% in 2031, 135.9% in 2032, 159.8% in 2033, 174.7% in 2034, 197.6% in 2035, 401.8% in 2040, and 741.8% in 2050, with bullish sentiment from 2027 onward.
A major floor 27.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.6% away) — a key level to hold.
The nearest ceiling, 27.3% above — a clean break opens room to run.
A major ceiling 37.5% above — clearing it would confirm fresh momentum.
Key CRDL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRDL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.30 | Sell | $1.30 | Sell |
| MA 10 | $1.31 | Sell | $1.31 | Sell |
| MA 20 | $1.32 | Sell | $1.32 | Sell |
| MA 50 | $1.31 | Sell | $1.29 | Sell |
| MA 100 | $1.16 | Buy | $1.22 | Buy |
| MA 200 | $1.12 | Buy | $1.19 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.84 | Neutral |
| Stoch RSI (14) | 22.38 | Neutral |
| CCI (20) | -111.68 | Sell |
| Williams %R (14) | -81.82 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -3.03 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 18.18 | Buy |
| TRIX (15) | -0.04 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 40.08 | Neutral |
| Momentum (10) | -0.07 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 1.30 | Sell |
| ADX (14) | 10.00 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture for CRDL shows bullish sentiment overall, with RSI(14) at 50. The price trades near the SMA50 of $1.30 and above the SMA200 of $1.11, with a support at $1.26 and a resistance at $1.63.
The 30-day range spans from $1.10 to $1.59, indicating a tight trading band around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.926 | $1.28 | $1.68 | 0% | Neutral | |
| $1.22 | $1.53 | $2.04 | +20% | Neutral | |
| $1.31 | $1.69 | $2.33 | +32% | Bullish | |
| $1.31 | $1.73 | $2.45 | +35% | Bullish | |
| $1.49 | $2.02 | $2.93 | +57% | Bullish | |
| $1.81 | $2.48 | $3.69 | +94% | Bullish | |
| $2.12 | $2.96 | $4.47 | +131% | Bullish | |
| $2.27 | $3.22 | $4.95 | +152% | Bullish | |
| $2.36 | $3.41 | $5.32 | +166% | Bullish | |
| $2.55 | $3.72 | $5.90 | +191% | Bullish | |
| $3.95 | $6.17 | $10.39 | +382% | Bullish | |
| $5.94 | $10.38 | $19.11 | +711% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.926 | $1.28 | $1.50 | +0.00% |
| June 2026 | $1.08 | $1.27 | $1.52 | -1.02% |
| July 2026 | $1.09 | $1.30 | $1.58 | +2.29% |
| August 2026 | $1.09 | $1.30 | $1.60 | +0.04% |
| September 2026 | $1.05 | $1.26 | $1.56 | -2.84% |
| October 2026 | $1.05 | $1.27 | $1.59 | +0.80% |
| November 2026 | $1.09 | $1.32 | $1.66 | +3.68% |
| December 2026 | $1.09 | $1.32 | $1.68 | +0.55% |
Click any year to see its month-by-month CRDL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CRDL to range from $0.926 to $1.68 through 2026. The $1.28 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CRDL price prediction for 2027 points to an average of $1.53 (low $1.22, high $2.04) — a potential gain of +20% on today's $1.28. A consolidation phase looks the most probable path here.
In 2028, CRDL is projected to trade between $1.31 and $2.33, averaging $1.69 — a potential gain of +32% from today's $1.28. That is up +10% on the projected 2027 average. Momentum favours further upside here.
Cardiol Therapeutics Inc.'s 2029 outlook centres on $1.73, within a $1.31 to $2.45 range. That is up +2% on the projected 2028 average. That marks a +35% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CRDL could reach as high as $2.93, with a base case around $2.02 and support toward $1.49 — roughly +57% from $1.28. Momentum favours further upside here.
Expect CRDL to range from $1.81 to $3.69 through 2031. The $2.48 average target implies a +94% move from current prices. That is up +23% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CRDL price prediction for 2032 points to an average of $2.96 (low $2.12, high $4.47) — a potential gain of +131% on today's $1.28. Momentum favours further upside here.
In 2033, CRDL is projected to trade between $2.27 and $4.95, averaging $3.22 — a potential gain of +152% from today's $1.28. That is up +9% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Cardiol Therapeutics Inc.'s 2034 outlook centres on $3.41, within a $2.36 to $5.32 range. That is up +6% on the projected 2033 average. That marks a +166% change versus current levels. Momentum favours further upside here.
By 2035, CRDL could reach as high as $5.90, with a base case around $3.72 and support toward $2.55 — roughly +191% from $1.28. Buyers look set to stay in control over this stretch.
Expect CRDL to range from $3.95 to $10.39 through 2040. The $6.17 average target implies a +382% move from current prices. That is up +66% on the projected 2035 average. Momentum favours further upside here.
The CRDL price prediction for 2050 points to an average of $10.38 (low $5.94, high $19.11) — a potential gain of +711% on today's $1.28. Buyers look set to stay in control over this stretch.
Investing $1,000 in CRDL today (≈ 781.25 CRDL) could be worth
$8,109.22
+$7,109.22 (+711%) by 2050 · US Dollar
Based on the average projected CRDL price of $10.38 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRDLwould be worth at today's price.
$1,000 invested in CRDL on May 27, 2025 (≈ 862.06899 CRDL) would be worth
$1,103.45
+$103.45 (+10.3%) today · 1.10× · US Dollar
Based on a CRDL entry price of $1.16 vs. today's $1.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.3 | $984.62 | -1.5% |
| 1 month ago | $1.4 | $914.29 | -8.6% |
| 3 months ago | $1.07 | $1,196.26 | +19.6% |
| 6 months ago | $1.05 | $1,219.05 | +21.9% |
| 1 year ago | $1.16 | $1,103.45 | +10.3% |
| All time (5.0y) ago | $2.7 | $474.07 | -52.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRDL forecast.
Our base-case forecast reaches $2.60 around 2032.
Implied market cap at $2.60: $299.71M
In 2026, the min price forecast is $0.926 and the average is $1.32, with a max of $1.73 and a 0% ROI, reflecting a neutral sentiment.
From 2027 onward, the outlook is bullish with rising averages and ROI: 2027 avg $1.59 (ROI 20.7%), 2028 avg $1.76 (ROI 33.3%), 2029 avg $1.78 (ROI 34.9%), 2030 avg $2.12 (ROI 60.6%), 2031 avg $2.64 (ROI 99.9%), 2032 avg $3.11 (ROI 135.9%), 2033 avg $3.43 (ROI 159.8%), 2034 avg $3.63 (ROI 174.7%), 2035 avg $3.93 (ROI 197.6%).
The multi-year horizon shows further upside, with 2040 averaging $6.62 (ROI 401.8%) and 2050 averaging $11.11 (ROI 741.8%), all accompanied by bullish sentiment.
Tap a question to reveal the answer.
In 2030 the average forecast price is $2.12, with a min of $1.56 and a max of $3.12, and a ROI of 60.6%. The sentiment is BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages and ROI, following a neutral reading in 2026. These are estimates and not guarantees.
Yes. The 2050 forecast targets a max of $20.84, an average of $11.11, a min of $6.19, with a ROI of 741.8% and a bullish sentiment.
The current price is $1.32.
The 30-day range is $1.10-$1.59. The moving averages are SMA50 at $1.30 and SMA200 at $1.11. There is support at $1.26 and resistance at $1.63. RSI(14) is 50 and the sentiment is BULLISH.
Cardiol Therapeutics Inc. Community Discussion
0Share your Cardiol Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.